Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 3
2002 1
2005 1
2006 1
2007 3
2008 8
2009 9
2010 4
2011 5
2012 7
2013 4
2014 8
2015 4
2016 6
2017 1
2018 1
2020 2
2021 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
T Cell Engineering.
Pircher M, Schirrmann T, Petrausch U. Pircher M, et al. Among authors: schirrmann t. Prog Tumor Res. 2015;42:110-35. doi: 10.1159/000437180. Epub 2015 Sep 4. Prog Tumor Res. 2015. PMID: 26383243 Review.
COR-101, ein menschlicher Antikörper gegen COVID-19.
Dübel S, Herrmann A, Schirrmann T, Frenzel A, Hust M. Dübel S, et al. Among authors: schirrmann t. Biospektrum (Heidelb). 2021;27(1):46-48. doi: 10.1007/s12268-021-1512-x. Epub 2021 Feb 12. Biospektrum (Heidelb). 2021. PMID: 33612989 Free PMC article. Review. German.
Rekombinante, vollständig humane Antikörper zur Behandlung akuter COVID-19.
Dübel S, Hust M, Frenzel A, Schirrmann T. Dübel S, et al. Among authors: schirrmann t. Biospektrum (Heidelb). 2020;26(4):444-446. doi: 10.1007/s12268-020-1404-4. Epub 2020 Jun 26. Biospektrum (Heidelb). 2020. PMID: 32834543 Free PMC article. German. No abstract available.
Designing Human Antibodies by Phage Display.
Frenzel A, Kügler J, Helmsing S, Meier D, Schirrmann T, Hust M, Dübel S. Frenzel A, et al. Among authors: schirrmann t. Transfus Med Hemother. 2017 Sep;44(5):312-318. doi: 10.1159/000479633. Epub 2017 Aug 25. Transfus Med Hemother. 2017. PMID: 29070976 Free PMC article. Review.
Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cells.
Lutz S, Klausz K, Albici AM, Ebinger L, Sellmer L, Teipel H, Frenzel A, Langner A, Winterberg D, Krohn S, Hust M, Schirrmann T, Dübel S, Scherließ R, Humpe A, Gramatzki M, Kellner C, Peipp M. Lutz S, et al. Among authors: schirrmann t. Front Immunol. 2023 Oct 27;14:1227572. doi: 10.3389/fimmu.2023.1227572. eCollection 2023. Front Immunol. 2023. PMID: 37965326 Free PMC article.
Selection of Recombinant Human Antibodies.
Tomszak F, Weber S, Zantow J, Schirrmann T, Hust M, Frenzel A. Tomszak F, et al. Among authors: schirrmann t. Adv Exp Med Biol. 2016;917:23-54. doi: 10.1007/978-3-319-32805-8_3. Adv Exp Med Biol. 2016. PMID: 27236551 Review.
Targeting antibodies to the cytoplasm.
Marschall AL, Frenzel A, Schirrmann T, Schüngel M, Dübel S. Marschall AL, et al. Among authors: schirrmann t. MAbs. 2011 Jan-Feb;3(1):3-16. doi: 10.4161/mabs.3.1.14110. Epub 2011 Jan 1. MAbs. 2011. PMID: 21099369 Free PMC article. Review.
CD30 as a therapeutic target for lymphoma.
Schirrmann T, Steinwand M, Wezler X, Ten Haaf A, Tur MK, Barth S. Schirrmann T, et al. BioDrugs. 2014 Apr;28(2):181-209. doi: 10.1007/s40259-013-0068-8. BioDrugs. 2014. PMID: 24043362 Review.
Phage display derived therapeutic antibodies.
Thie H, Meyer T, Schirrmann T, Hust M, Dübel S. Thie H, et al. Among authors: schirrmann t. Curr Pharm Biotechnol. 2008 Dec;9(6):439-46. doi: 10.2174/138920108786786349. Curr Pharm Biotechnol. 2008. PMID: 19075684 Review.
Production systems for recombinant antibodies.
Schirrmann T, Al-Halabi L, Dübel S, Hust M. Schirrmann T, et al. Front Biosci. 2008 May 1;13:4576-94. doi: 10.2741/3024. Front Biosci. 2008. PMID: 18508530 Review.
67 results